NewsRx

Search our medical news database

Clarient, Inc.

Clarient Generates 61% Increase in First Quarter 2007 Revenues From Continuing Operations

Published in Law and Health Weekly, May 19th, 2007

Clarient, Inc. (NASDAQ:CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, announced financial results for the first quarter ended March 31, 2007. Total net revenue from continuing operations was $8.9 million for the first quarter 2007, an increase of 61 percent as compared to $5.5 million in the comparable period 2006. Revenue from continuing operations consists of revenue from Clarient's diagnostic services business, which after the recent divestiture of the Company's Instrument Systems business, is Clarient's business focus.

Commenting on the Company's results, Clarient's President and CEO Ron Andrews said,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook